PureTech Health PLC PureTech to Present at Jefferies Conference

TIDMPRTC

PureTech Health PLC

02 November 2016

2 November 2016

PureTech Health plc

PureTech Health to Present at the Jefferies 2016 Healthcare Conference in London

PureTech Health plc ("PureTech" or the "Company", LSE: PRTC), a cross-disciplinary biotech company developing 21(st) century medicines, today announced that Daphne Zohar, PureTech Health's Chief Executive Officer, will present at the Jefferies 2016 London Healthcare Conference on Wednesday, 16 November, at 4:00pm GMT.

A webcast of the presentation will be available at http://puretechhealth.com/investors.php under the Reports and Presentations tab.

About PureTech Health

PureTech Health (PureTech Health plc, PRTC.L) is a cross-disciplinary biotech company creating 21(st) century medicines that modulate the adaptive human systems. Our therapies target the immune, nervous, and gastro-intestinal systems by addressing the underlying pathophysiology of disease from a systems perspective rather than through a single receptor or pathway. We are advancing more than 20 clinical studies across our pipeline, with five human proof-of-concept studies and multiple pivotal or registration studies expected to read out in the next two years. PureTech Health's rich and growing research and development pipeline has been developed in collaboration with some of the world's leading scientific experts, who along with PureTech's experienced team and board analyse more than 650 scientific discoveries per year to identify and advance the opportunities we believe hold the most promise for patients. This process places PureTech Health on the cutting edge of ground-breaking science and technological innovation and leads the Company between and beyond existing disciplines. For more information, visit www.puretechhealth.com or connect with us on Twitter.

Forward Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to the company's future prospects, developments and strategies. The forward- looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk factors included in the company's regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of the company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure and Transparency Rules, neither the company nor any other party intends to update or revise these forward- looking statements, whether as a result of new information, future events or otherwise.

# # #

For further information, please contact:

 
 PureTech                                  [phone] 
 Allison Mead, Director, Communications 
  and Investor Relations 
 
 FTI Consulting (Communications            [phone] 
  adviser to PureTech)                      1000 
 Ben Atwell 
  Matthew Cole 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAAKBDKKBDKDDK

(END) Dow Jones Newswires

November 02, 2016 03:00 ET (07:00 GMT)